Rchr
J-GLOBAL ID:200901009829701940
Update date: Oct. 24, 2024
Toi Masakazu
トイ マサカズ | Toi Masakazu
Affiliation and department:
Research field (1):
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (19):
- 2023 - 2028 SR-PETによる各種腫瘍のSSTR発現評価とPRRT適応可能性の検証
- 2019 - 2022 間質応答を利用したホルモン受容体陽性乳がんの治療戦略の構築
- 2018 - 2021 Development of breast cancer serum diagnostic method using NMR measurement based on a new concept
- 2016 - 2020 Development of advanced photoacoustic imaging system based on integration of optics and ultrasound and control of optical phase space
- 2016 - 2019 Epigenetic profiling of cfDNA in breast cancer samples
- 2015 - 2018 Study on quality, usefulness and ELSI of genetic testing including NGS analysis.
- 2013 - 2016 Ultrasound viscoelastography: development of quantitative imaging of tissue viscoelasticity based on fusion of static and dynamic tissue excitation
- 2012 - 2016 Biological optimal dosing of anti-neoplastic in order to maximize therapeutic efficacy and safety
- 2012 - 2016 Molecular mechanism in direct effect of VEGF onto breast cancer cells
- 2014 - 2015 Development of new breast cancer detection method by the serous samples
- 2012 - 2015 Evaluation of quality and usefullness of genetics testing-clinical application of next generation sequencer.
- 2012 - 2015 Bayesian study designs for new drug development in early-stage cancer clinical trials.
- 2010 - 2012 Development of advanced bioimaging technology based on integration of optics and ultrasound by spatio-temporal modulation
- 2009 - 2011 Research on functional analysis of circulating tumor cells in association with cancer metastasis.
- 2008 - 2010 Application of microRNA profilling to breast cancer diagnosis and therapy
- 2007 - 2008 蛋白多項目解析の基盤技術確立と臨床応用
- 2007 - 2008 Analysis and clinical application of normal blood vessel inducement by Int6-siRNA
- 1989 - 1990 Studies on the Scoring System of Diagnosis Using Thermography for Breast Cancer and its Clinical Application
- -
Show all
Papers (842):
-
Tomomi Nishimura, Ravi Velaga, Norikazu Masuda, Kosuke Kawaguchi, Shuji Kawaguchi, Masahiro Takada, Yurina Maeshima, Sunao Tanaka, Yuichiro Kikawa, Takayuki Kadoya, et al. Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors. Cancer science. 2024
-
Tomohiro Nishiyama, Ayane Yamaguchi, Peitao Han, Lis Weiji Kanashiro Pereira, Yuka Otsuki, Gabriel Herman Bernardim Andrade, Noriko Kudo, Shuntaro Yada, Shoko Wakamiya, Eiji Aramaki, et al. Automated System to Capture Patient Symptoms From Multitype Japanese Clinical Texts: Retrospective Study. JMIR Medical Informatics. 2024. 12. e58977-e58977
-
Akane Higami, Masahiro Takada, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Kosuke Kawaguchi, Ayane Yamaguchi, Yasuhide Takeuchi, Yosuke Yamada, Masakazu Toi. Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients. International Journal of Clinical Oncology. 2024
-
Yurina Maeshima, Tatsuki R Kataoka, Alexis Vandenbon, Masahiro Hirata, Yasuhide Takeuchi, Yutaka Suzuki, Yukiko Fukui, Masahiro Kawashima, Masahiro Takada, Yumiko Ibi, et al. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals a reduction in CD169+ macrophages within metastatic breast cancers. EBioMedicine. 2024. 107. 105271-105271
-
前島 佑里奈, 片岡 竜貴, Vandenbon Alexis, 平田 勝啓, 竹内 康英, 鈴木 穣, 福井 由紀子, 川島 雅央, 高田 正泰, 揖斐 裕実子, et al. 乳癌浸潤リンパ節におけるCD169陽性マクロファージの選択的排除(Selective elimination of CD169+ macrophages in lymph nodes invaded by breast cancers). 日本乳癌学会総会プログラム抄録集. 2024. 32回. 51-51
more...
MISC (451):
-
鈴木 貴, 藤島 史喜, 田中 美桜, 片岡 正子, 戸井 雅和. 乳腺診療における技術革新 デジタルパソロジー 遠隔病理診断とAI(人工知能). 日本外科学会定期学術集会抄録集. 2024. 124回. SY-2
-
弓削瞬介, 三宅可奈江, 高田正泰, 志水陽一, 北野香雪, 片岡正子, 石守崇好, 川島雅央, 河口浩介, 戸井雅和, et al. 浸潤性小葉癌におけるF-18FES PETの有用性. 核医学(Web). 2023. 60. Supplement
-
三宅可奈江, 高田正泰, 志水陽一, 弓削瞬介, 北野香雪, 石守崇好, 片岡正子, 板垣孝治, 川島雅央, 戸井雅和, et al. De novo ER陽性乳癌における[F-18]-FES PETの診断能:全身PET/CTと乳房PET/MRの比較. 核医学(Web). 2023. 60. Supplement
-
橋本陽菜, 片岡正子, 藤本晃司, 藤本晃司, 飯間麻美, 飯間麻美, 戸井雅和, 川瀬貫互, 大橋茜, 大橋茜, et al. Quantification of Tumor-Related Vessel Length on UF-DCE MRI and Their Association with Breast Cancer Subtypes [Presidential Award Proceedings]. 日本磁気共鳴医学会雑誌(Web). 2023. 43. 2
-
弓削瞬介, 三宅可奈江, 片岡正子, 八上全弘, 磯田裕義, 石守崇好, 松本純明, 高田正泰, 戸井雅和, 中本裕士. 任意型検診における乳房専用PETの診断能-初診群と再診群による比較-. 核医学(Web). 2022. 59. Supplement
more...
Lectures and oral presentations (1):
-
Management of Residual Disease after Neo-adjuvant CT in Her2 neu positive Breast Cancer.
(2019)
Return to Previous Page